查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018718

心臟外科手術器械市場：按產品類型、材料、應用和最終用戶分類－2026-2032年全球市場預測

Cardiac Surgery Instruments Market by Product Type, Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，心臟外科手術器械市場價值將達到 30 億美元，到 2026 年將成長至 31.2 億美元，到 2032 年將達到 41.6 億美元，複合年成長率為 4.78%。

主要市場統計數據
基準年 2025 30億美元
預計年份：2026年 31.2億美元
預測年份 2032 41.6億美元
複合年成長率 (%) 4.78%

對心臟外科手術器械市場進行權威分析，並從器械創新、臨床需求和採購趨勢等角度分析影響策略決策的因素。

心臟外科器械生態系統已發展成熟，成為醫療設備創新、不斷演進的外科技術和供應鏈韌性之間錯綜複雜的相互作用網路。本執行摘要對當前市場動態進行了全面分析，重點關注影響臨床實踐和商業策略的關鍵趨勢。此外，本概要也將技術進步置於全面影響採購、臨床結果和供應商競爭的許多因素中進行探討，這些因素包括不斷變化的手術偏好、監管以及材料科學的進步。

心胸醫療設備的研發、實務和價值鏈策略發生了重大變革，重新定義了臨床和商業性價值的創造。

一系列變革正在重塑心臟外科手術器械的臨床實踐和商業性模式。生物材料和合成移植物工程的進步提高了生物相容性和長期耐久性，而電外科技術的改進和泵送技術的進步則減少了術中組織損傷並改善了灌注控制。同時，醫療設備的模組化和數位化整合實現了更智慧的器材選擇和術中回饋迴路，為臨床醫生提供數據，以輔助即時決策和術後品質評估。

2025 年關稅政策轉變將如何推動整個心臟設備生態系統的供應鏈重組、製造本地化和總擁有成本 (TCO) 重新評估。

2025年關稅的實施將為全球採購流程帶來顯著的摩擦，迫使醫院、手術網路和醫療設備供應商重新評估其籌資策略和成本分攤機制。關稅措施提高了本地生產和近岸外包的相對吸引力，加速了關於重組生產基地和供應商多元化的討論。因此，採購團隊越來越關注總體擁有成本（TCO）的各個方面，包括關稅、物流、庫存持有成本以及供應商整合和替代對其營運的影響。

透過詳細的細分分析，揭示產品類型、臨床應用、最終用戶環境和材料類別如何相互交織，從而產生差異化需求。

基於細分市場的洞察揭示了不同產品類型、臨床應用、終端用戶和材料分類的需求模式和競爭動態。就產品類型而言，主動脈移植物呈現出生物移植物優先考慮生物整合性，而合成移植物則強調長期耐用性，兩者之間存在顯著差異。同樣，心肺體外迴圈系統也存在性能預期上的分歧：離心式幫浦系統因其低血流量而備受青睞，而滾壓泵系統則因其熟悉性和成本效益而備受青睞。電外科設備分為提供集中能量輸出的雙極設備和滿足各種外科手術需求的單極設備。心臟瓣膜也呈現出明顯的差異：機械瓣膜提供卓越的耐用性，而組織瓣膜則解決了抗凝血問題。外科縫合線和縫合釘包括用於臨時傷口支撐的可吸收縫合線、永久性傷口閉合的不可吸收縫合線以及用於快速閉合的縫合釘。血管閉塞解決方案包括用於機械閉塞的血管夾和用於輔助止血的血管密封劑。

影響臨床應用和商業性成功的區域趨勢和市場進入現實情況，包括美洲、歐洲、中東和非洲以及亞太地區。

區域趨勢對臨床應用模式、監管應對措施和商業策略有顯著影響。在美洲，一體化的醫院系統、對手術效率的重視以及支付方對已證實臨床和經濟價值的嚴格審查，正在推動市場需求。在這種環境下，能夠提供臨床差異化優勢、擁有可預測的供應鏈和長期維護支援的醫療器材更具優勢。歐洲、中東和非洲地區的市場環境複雜多樣，監管協調、醫療設備基礎設施差異以及不斷變化的報銷政策既帶來了挑戰，也蘊藏著獨特的市場機會。在這些市場取得成功往往取決於強大的本地夥伴關係關係和靈活的定價模式。在全部區域，產能的快速擴張、對微創手術基礎設施的投資以及對本土製造的日益重視，正在打造一個充滿活力的市場，能夠滿足區域特定臨床需求和監管要求的靈活製造商將獲得豐厚的回報。

競爭對手和策略夥伴關係關係推動心臟外科醫療設備製造商和專業創新者的創新、市場准入和臨床部署。

心臟外科手術器材市場的競爭格局由成熟的醫療設備製造商、新興的專業創新者以及加速臨床檢驗和拓展分銷網路的戰略夥伴關係共同構成。主要企業通常透過整合解決方案、豐富的產品系列以及對臨床證據和上市後監測的持續投入來脫穎而出。而專注於特定領域的企業則傾向於運用特定技術解決外科手術難題，例如用於複雜血管閉合的改良型密封劑或具有更強操作性能的新一代縫合線，從而在臨床市場站穩腳跟。

產業領導者面臨的實際策略挑戰，重點在於臨床證據、製造靈活性、模組化平台和先進的商業模式。

產業領導者應採取多管齊下的策略，將產品創新與臨床工作流程的整合、監管前瞻性和供應鏈韌性相結合。首先，投資於轉化臨床研究，將醫療設備的表現與諸如縮短手術時間、降低併發症率和改善患者復健等有意義的臨床結果聯繫起來。此類證據不僅能推動產品在臨床環境中的應用，還能加強與支付方和醫院系統基於價值的合約談判。其次，優先考慮靈活的製造地地點和近岸外包方案，以便快速回應當地需求波動，同時降低關稅和物流波動風險的影響。第三，設計模組化產品平台，使單一核心系統能夠應用於多種手術，從而簡化醫療保健客戶的採購和庫存管理。

臨床和商業性研究結果透過嚴格的混合方法調查檢驗，該調查結合了對臨床醫生的訪談、監管審查和供應鏈分析。

本分析的調查方法結合了定性和定量方法，以確保結果的全面性和平衡性。主要資訊來源是對執業心臟外科醫生、醫院採購經理、臨床工程師和製造公司高管的訪談，以收集關於醫療設備性能、手術趨勢和採購行為的第一手觀點。此外，還對監管指南、臨床試驗論文和衛生技術評估（HTA）進行了系統性回顧，以支持臨床和安全性方面的論點。

全面概述了創新、供應鏈韌性和區域差異，這些差異定義了心臟外科器械相關人員面臨的策略挑戰。

總之，心臟外科器械市場正處於轉折點，其驅動力來自材料創新、外科技術進步和貿易趨勢的轉變。生物材料的改進、先進的電外科和灌注技術，以及微創和混合手術的興起，正在催生不同產品類型和臨床應用領域的多樣化需求。關稅相關的干擾因素提升了製造地接近性和供應鏈柔軟性的戰略重要性，迫使企業重新評估籌資策略，並將總體擁有成本 (TCO) 置於優先地位。區域差異進一步加劇了競爭格局分析的複雜性，凸顯了製定區域性打入市場策略和深入了解監管環境的必要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 心臟外科手術器械市場：依產品類型分類

  • 主動脈移植
    • 生物移植
    • 合成接枝
  • 心肺體外迴圈系統
    • 離心式幫浦浦系統
    • 滾筒幫浦系統
  • 電外科設備
    • 雙極裝置
    • 單極裝置
  • 心臟瓣膜
    • 機械閥
    • 組織瓣膜
  • 手術縫線和縫合釘
    • 可吸收縫線
    • 不可吸收縫線
    • 手術釘
  • 血管閉合裝置
    • 血管夾
    • 血管密封劑

第9章：心臟外科手術器械市場：依材料分類

  • 生物材料產品
  • 金屬樂器
  • 聚合物儀器

第10章：心臟外科手術器械市場：依應用領域分類

  • 主動脈瘤修復
    • 血管內修復
    • 開胸手術
  • 先天性心臟疾病矯正
    • ASD 閉合
    • 室間隔缺損（VSD）修補術
  • 冠狀動脈繞道手術手術
    • 非體外迴圈冠狀動脈繞道手術手術
    • 在保持心率下冠狀動脈繞道手術手術
  • 心臟瓣膜修復和置換
    • 主動脈瓣修補
    • 二尖瓣修復

第11章 心臟外科手術器械市場：依最終使用者分類

  • 門診手術中心
  • 醫院
  • 專科診所

第12章 心臟外科手術器械市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 心臟外科手術器械市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 心臟外科手術器械市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國心臟外科手術器械市場

第16章：中國心血管外科器械市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Abiomed, Inc.
  • Berlin Heart GmbH
  • Boston Scientific Corporation
  • Braile Biomedica Ltda.
  • CardiacAssist, Inc.
  • Cyberonics, Inc.
  • Edwards Lifesciences Corporation
  • Getinge AB
  • HeartWare International, Inc.
  • Jarvik Heart, Inc.
  • LivaNova PLC
  • MAQUET Holding BV & Co. KG.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Sorin Group
  • St. Jude Medical, LLC
  • SynCardia Systems, LLC
  • Terumo Corporation
  • Thoratec Corporation
Product Code: MRR-AD36CD89859B

The Cardiac Surgery Instruments Market was valued at USD 3.00 billion in 2025 and is projected to grow to USD 3.12 billion in 2026, with a CAGR of 4.78%, reaching USD 4.16 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.00 billion
Estimated Year [2026] USD 3.12 billion
Forecast Year [2032] USD 4.16 billion
CAGR (%) 4.78%

An authoritative framing of the cardiac surgery instruments landscape that contextualizes device innovation, clinical demand, and procurement dynamics shaping strategic decisions

The cardiac surgery instruments ecosystem has matured into a complex interplay of device innovation, procedural change, and supply chain resilience. This executive summary synthesizes the prevailing market dynamics and draws attention to the most consequential developments shaping clinical practice and commercial strategy. It frames the technological progress in a context of evolving procedural preferences, regulatory oversight, and material science advancements that collectively influence procurement, clinical outcomes, and vendor competitiveness.

Clinicians continue to demand devices that afford greater precision, shorter procedural times, and predictable hemostasis, while hospital systems prioritize durability, cost-control, and inventory rationalization. Consequently, manufacturers are responding with modular product architectures, refined biomaterials, and integrated surgical systems that aim to lower intraoperative complexity. As the sector progresses, collaboration across clinical, regulatory, and manufacturing domains will determine which innovations become standards of care versus niche adjuncts. This introduction sets the stage for the subsequent sections, which examine transformative shifts, tariff impacts, segmentation-specific insights, regional dynamics, competitive positioning, actionable recommendations, and the methodological approach underpinning the analysis.

Critical transformative shifts in cardiothoracic device development, procedural practice, and supply chain strategies that are redefining clinical and commercial value creation

A series of transformative shifts is reshaping both clinical practice and commercial approaches in cardiac surgery instrumentation. Advances in biomaterials and synthetic graft engineering are improving biocompatibility and long-term durability, while electrosurgical refinement and enhanced pump technologies are reducing intraoperative trauma and improving perfusion control. Meanwhile, the convergence of device modularity and digital integration enables smarter instrument selection and intraoperative feedback loops, providing clinicians with data that can inform real-time decisions and post-procedural quality assessments.

Concurrently, procedural evolution such as increased uptake of minimally invasive and hybrid approaches is altering product demand profiles, with enhanced demand for smaller footprint devices and adaptable valve solutions. Supply chain resilience and manufacturing agility have become central priorities for market participants, prompting investment in regional manufacturing hubs and dual-sourcing strategies. Collectively, these shifts are redefining the value equation for purchasers and creating opportunities for manufacturers that can demonstrate clinically substantiated improvements in outcomes alongside predictable cost curves.

How 2025 tariff policy shifts are compelling supply chain realignment, manufacturing localization, and total cost of ownership reassessments across the cardiac devices ecosystem

The introduction of tariffs in 2025 has introduced notable friction into global procurement flows, compelling hospitals, surgical networks, and device vendors to reassess sourcing strategies and cost allocation mechanisms. Tariff measures have increased the comparative attractiveness of local manufacturing and nearshoring, accelerating conversations about production footprint realignment and supplier diversification. As a result, procurement teams are emphasizing total cost of ownership considerations, including duties, logistics, inventory holding costs, and the operational impacts of supplier consolidation or substitution.

In response, several manufacturers have adjusted contractual terms and explored tariff-mitigation tactics such as tariff engineering, tariff classification reviews, and increased manufacturing localization. These approaches aim to preserve competitive pricing while maintaining supply reliability. Additionally, the tariff environment has stimulated renewed focus on product rationalization, compelling healthcare providers to streamline device formularies and prioritize multi-use platforms that can span procedural indications without incurring significant incremental duty exposure. The cumulative effect has been a reshuffling of strategic priorities that favors supply chain resilience, manufacturing flexibility, and the capacity to demonstrate predictable cost structures under changing trade regimes.

Deep segmentation intelligence revealing how product types, clinical applications, end-user settings, and material classes intersect to drive differentiated demand

Segmentation-driven insights reveal differentiated demand patterns and competitive dynamics across product types, clinical applications, end users, and material classes. Within product typologies, aortic grafts exhibit bifurcated requirements between biological grafts that prioritize host integration and synthetic grafts that emphasize long-term durability; cardiopulmonary bypass systems are marked by divergent performance expectations between centrifugal pump systems, prized for reduced blood trauma, and roller pump systems, valued for familiarity and cost-effectiveness. Electrosurgical devices separate into bipolar devices that offer focused energy delivery and monopolar devices that continue to serve broad surgical needs. Heart valves present a clear split between mechanical valves that deliver exceptional longevity and tissue valves that address anticoagulation concerns, while surgical sutures and staples cover absorbable sutures for transient wound support, non-absorbable sutures for permanent approximation, and staples for rapid closure. Vessel closure solutions span vascular clips for mechanical occlusion and vascular sealants for adjunct hemostasis.

Application-based distinctions further refine demand: aortic aneurysm repair differentiates endovascular repair from open surgery with distinct device profiles; congenital heart defect correction emphasizes device miniaturization and precision in ASD closure and VSD closure; coronary artery bypass grafting continues to support both off-pump CABG and on-pump CABG workflows, each dictating specific instrumentation; heart valve repair and replacement segments highlight different device attributes for aortic valve repair versus mitral valve repair. End user segmentation illustrates deployment contexts across ambulatory surgical centers, hospitals, and specialty clinics, each with unique procurement cycles, inventory constraints, and clinical throughput expectations. Material classification-biological products, metal instruments, and polymer instruments-shapes regulatory pathways, sterilization protocols, and user preferences. Understanding how these segmentation axes intersect is essential for tailoring product development, clinical evidence generation, and commercial go-to-market strategies.

Regional dynamics and market access realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine clinical uptake and commercial success

Regional dynamics exert a profound influence on clinical adoption patterns, regulatory pathways, and commercial strategy. In the Americas, demand is driven by consolidated hospital systems, a focus on procedural efficiency, and payer scrutiny that rewards demonstrable clinical and economic value. This environment favors devices that combine clinical differentiation with predictable supply chains and long-term maintenance support. The Europe, Middle East & Africa region presents a heterogeneous landscape where regulatory harmonization, variable healthcare infrastructure, and evolving reimbursement policies create both challenges and niche opportunities; success in these markets is often predicated on strong local partnerships and adaptive pricing models. Across Asia-Pacific, rapid capacity expansion, investments in minimally invasive surgery infrastructure, and a growing focus on domestic manufacturing create a dynamic market that rewards agile manufacturers capable of addressing localized clinical needs and regulatory requirements.

These regional nuances require tailored commercial approaches, from clinical evidence generation strategies to distribution partnerships and localized manufacturing investments. Manufacturers that align product portfolios with regional procedural preferences and that invest in regulatory expertise and market-specific clinician engagement will be better positioned to capture long-term value in diverse geographies.

Competitive dynamics and strategic partnerships driving innovation, market entry, and clinical adoption across cardiac surgery device manufacturers and specialty innovators

Competitive landscapes in cardiac surgery instruments are shaped by a mix of established device manufacturers, emerging specialized innovators, and strategic partnerships that accelerate clinical validation and distribution reach. Leading firms typically differentiate through integrated solutions, broad product portfolios, and sustained investments in clinical evidence and post-market surveillance. Meanwhile, niche players frequently secure clinical footholds by addressing specific procedural pain points with focused technologies-such as refined sealants for complex vascular closures or next-generation sutures that improve handling characteristics.

Strategic alliances and acquisitions continue to be pivotal in consolidating technological capabilities and expanding geographic reach. Collaboration between device makers and clinical research networks facilitates faster evidence generation and improved adoption curves, while partnerships with contract manufacturers and logistics providers enhance supply chain resilience. Market incumbents that combine robust clinical datasets, scalable manufacturing, and flexible commercial models maintain distinct competitive advantages, though innovators that can demonstrate clear procedural benefits and cost-effectiveness in targeted use cases can rapidly disrupt established patterns.

Actionable strategic imperatives for industry leaders focusing on clinical evidence, manufacturing agility, modular platforms, and progressive commercial models

Industry leaders should pursue a multifaceted strategy that aligns product innovation with clinical workflow integration, regulatory foresight, and supply chain resilience. First, invest in translational clinical research that ties device performance to meaningful outcomes such as reduced operative time, lower complication rates, and improved patient recovery trajectories. Such evidence not only supports clinical adoption but also strengthens value-based contracting conversations with payers and hospital systems. Second, prioritize flexible manufacturing footprints and nearshoring options to mitigate tariff impacts and logistic volatility while enabling faster responsiveness to local demand shifts. Third, design product platforms with modularity in mind so that a single core system can be adapted across multiple procedures, thereby simplifying procurement and inventory management for institutional customers.

Additionally, cultivate deeper clinician partnerships through targeted training, simulation-based onboarding, and shared outcomes tracking to accelerate user confidence and to collect real-world evidence. Finally, adopt commercial models that allow for subscription or outcome-based pricing where feasible, offering predictable budgets for purchasers and recurring revenue streams for manufacturers. By synchronizing clinical evidence, manufacturing agility, and progressive commercial approaches, industry leaders can secure sustainable advantages in an evolving market.

A rigorous mixed-methods research approach combining clinician interviews, regulatory review, and supply chain analysis to validate clinical and commercial insights

The research methodology underpinning this analysis combined qualitative and quantitative approaches to ensure comprehensive validity and balanced interpretation. Primary inputs included interviews with practicing cardiac surgeons, hospital procurement leaders, clinical engineers, and senior executives within manufacturing organizations to capture firsthand perspectives on device performance, procedural trends, and buying behaviors. These insights were complemented by a structured review of regulatory guidances, clinical trial publications, and health technology assessments to corroborate clinical and safety narratives.

Secondary analysis evaluated publicly available regulatory filings, product dossiers, and peer-reviewed literature to map technological advancements and material performance characteristics. Supply chain and tariff implications were assessed through industry logistics reports and supplier interviews to understand practical impacts on sourcing and manufacturing decisions. Throughout, triangulation of inputs and cross-validation between data sources supported a robust interpretation of trends, while expert review ensured that the conclusions reflect current clinical practice and commercial realities.

Concluding synthesis of innovation, supply chain resilience, and regional nuances that define strategic imperatives for cardiac surgery instrument stakeholders

In conclusion, the cardiac surgery instruments landscape is at an inflection point driven by material innovation, procedural evolution, and evolving trade dynamics. The convergence of improved biomaterials, refined electrosurgical and perfusion technologies, and a shift toward minimally invasive and hybrid procedures is creating differentiated demand across product categories and clinical applications. Tariff-related disruptions have elevated the strategic importance of manufacturing proximity and supply chain flexibility, prompting organizations to reassess sourcing strategies and to prioritize total cost of ownership. Regional variations further complicate the competitive calculus, underscoring the need for localized go-to-market strategies and regulatory acumen.

Looking ahead, manufacturers that pair compelling clinical evidence with agile manufacturing and adaptive commercial models will be best positioned to meet the needs of diverse end users-from ambulatory surgical centers to tertiary hospitals and specialty clinics. Strategic collaboration with clinicians and supply chain partners will accelerate adoption and ensure that device innovation translates into measurable patient and operational benefits. The pathways to success are clear: prioritize clinically meaningful innovation, build resilient supply chains, and engage purchasers with outcome-oriented value propositions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cardiac Surgery Instruments Market, by Product Type

  • 8.1. Aortic Grafts
    • 8.1.1. Biological Grafts
    • 8.1.2. Synthetic Grafts
  • 8.2. Cardiopulmonary Bypass Systems
    • 8.2.1. Centrifugal Pump Systems
    • 8.2.2. Roller Pump Systems
  • 8.3. Electrosurgical Devices
    • 8.3.1. Bipolar Devices
    • 8.3.2. Monopolar Devices
  • 8.4. Heart Valves
    • 8.4.1. Mechanical Valves
    • 8.4.2. Tissue Valves
  • 8.5. Surgical Sutures And Staples
    • 8.5.1. Absorbable Sutures
    • 8.5.2. Non-Absorbable Sutures
    • 8.5.3. Surgical Staples
  • 8.6. Vessel Closure Devices
    • 8.6.1. Vascular Clips
    • 8.6.2. Vascular Sealants

9. Cardiac Surgery Instruments Market, by Material

  • 9.1. Biological Products
  • 9.2. Metal Instruments
  • 9.3. Polymer Instruments

10. Cardiac Surgery Instruments Market, by Application

  • 10.1. Aortic Aneurysm Repair
    • 10.1.1. Endovascular Repair
    • 10.1.2. Open Surgery
  • 10.2. Congenital Heart Defect Correction
    • 10.2.1. ASD Closure
    • 10.2.2. VSD Closure
  • 10.3. Coronary Artery Bypass Grafting
    • 10.3.1. Off-Pump CABG
    • 10.3.2. On-Pump CABG
  • 10.4. Heart Valve Repair And Replacement
    • 10.4.1. Aortic Valve Repair
    • 10.4.2. Mitral Valve Repair

11. Cardiac Surgery Instruments Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Cardiac Surgery Instruments Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Cardiac Surgery Instruments Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Cardiac Surgery Instruments Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Cardiac Surgery Instruments Market

16. China Cardiac Surgery Instruments Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Abiomed, Inc.
  • 17.7. Berlin Heart GmbH
  • 17.8. Boston Scientific Corporation
  • 17.9. Braile Biomedica Ltda.
  • 17.10. CardiacAssist, Inc.
  • 17.11. Cyberonics, Inc.
  • 17.12. Edwards Lifesciences Corporation
  • 17.13. Getinge AB
  • 17.14. HeartWare International, Inc.
  • 17.15. Jarvik Heart, Inc.
  • 17.16. LivaNova PLC
  • 17.17. MAQUET Holding B.V. & Co. KG.
  • 17.18. Medtronic plc
  • 17.19. MicroPort Scientific Corporation
  • 17.20. Sorin Group
  • 17.21. St. Jude Medical, LLC
  • 17.22. SynCardia Systems, LLC
  • 17.23. Terumo Corporation
  • 17.24. Thoratec Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SYNTHETIC GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SYNTHETIC GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SYNTHETIC GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CENTRIFUGAL PUMP SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CENTRIFUGAL PUMP SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CENTRIFUGAL PUMP SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ROLLER PUMP SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ROLLER PUMP SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ROLLER PUMP SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIPOLAR DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIPOLAR DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIPOLAR DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MONOPOLAR DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MONOPOLAR DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MONOPOLAR DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MECHANICAL VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MECHANICAL VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MECHANICAL VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY TISSUE VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY TISSUE VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY TISSUE VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ABSORBABLE SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ABSORBABLE SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ABSORBABLE SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY NON-ABSORBABLE SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY NON-ABSORBABLE SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY NON-ABSORBABLE SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL STAPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL STAPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL STAPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR SEALANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR SEALANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR SEALANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY METAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY METAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY METAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY POLYMER INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY POLYMER INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY POLYMER INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ENDOVASCULAR REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ENDOVASCULAR REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ENDOVASCULAR REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ASD CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ASD CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ASD CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VSD CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VSD CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VSD CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OFF-PUMP CABG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OFF-PUMP CABG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OFF-PUMP CABG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ON-PUMP CABG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ON-PUMP CABG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ON-PUMP CABG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC VALVE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC VALVE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC VALVE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MITRAL VALVE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MITRAL VALVE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MITRAL VALVE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. GCC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. GCC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. GCC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 267. GCC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 268. GCC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 269. GCC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 270. GCC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, 2018-2032 (USD MILLION)
  • TABLE 271. GCC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 272. GCC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 273. GCC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. GCC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, 2018-2032 (USD MILLION)
  • TABLE 275. GCC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, 2018-2032 (USD MILLION)
  • TABLE 276. GCC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 277. GCC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 278. GCC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION CARDIAC SURGERY INS